Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
6.133
Zitationen
11
Autoren
2001
Jahr
Abstract
Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
Ähnliche Arbeiten
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 · 28.965 Zit.
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 · 26.838 Zit.
APACHE II
1985 · 13.505 Zit.
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 · 13.152 Zit.
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
1996 · 11.408 Zit.